RITA BURNS: Open Payments
NPI 1376141135 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,084 in 56 payments from 18 companies in 2025. Trend: 2023 $149 · 2024 $1,534 · 2025 $1,084
Food & beverage: $1,084
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $299 |
| Janssen Biotech, Inc. | 5 | $199 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $77 |
| Ardelyx, Inc. | 3 | $64 |
| Aimmune Therapeutics, Inc. | 3 | $60 |
| Regeneron Healthcare Solutions, Inc. | 3 | $56 |
| Lilly USA, LLC | 3 | $52 |
| Celltrion USA Inc. | 3 | $51 |
| PFIZER INC. | 2 | $34 |
| Exact Sciences Corporation | 1 | $32 |
Products named: RINVOQ, TREMFYA, DUPIXENT, IBSRELA, ENTYVIO, OMVOH, VEGZELMA, VOWST.
Industry payments across NJ — which companies pay providers there.
